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Determining the Effects of Psychosocial Interventions on Quality of Life for
Cancer Patients: Analysis of Pilot Data and Recommendations for Full
Experimental Design and Statistical Analysis

Introduction
Anxiety, depression, and other symptoms of psychological stress are
generally observed to be increased in patients diagnosed with cancer [1-4].
Attempts to alleviate these adverse consequences to quality of life experienced by
cancer patients have led to the development of various psychological and
psychosocial interventions, or “wellness” programs. One popular approach is
called mindful meditation or mindfulness based stress reduction; in fact, Carlson
et al.(2003) reported that there were over 240 such programs in North America
[3]. The successful completion of a meditation program has been associated with
improvements in quality of life, as measured by multiple psychometric scales,
such as the European Organization for Research and Treatment of Cancer Quality
of Life Questionnaire (EORTC QLQ-C30), the Profile of Mood States (POMS),
Symptoms of Stress Inventory (SOSI) [5,6]. Similar benefit has also been seen in
cancer patients who participate in yoga programs or who study yoga
independently [6]. Aside from meditation, yoga, and other nontraditional
wellness programs, more conventional psychological counseling programs are
widely offered to oncology patients. Data in the literature suggest that a variety
of wellness interventions is capable of leading to stress reduction in cancer
patients, even for those patients receiving chemotherapy at the time [7].
Newell et al.(2002) noted in a review of the literature that over 600 papers
have been published concerning the evaluation of psychological therapies for
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cancer patients [8]. The papers reviewed by Newell et al. spanned many types of
psychosocial programs, such as traditional counseling, cancer education,
meditation, hypnosis, and music therapy; many forms of intervention
administration, such as individual sessions, group sessions, and audiotape; and a
wide range of targeted effects, such as decreased stress, hostility, depression, and
anxiety, or improved immune response and overall quality of life. Although each
study tended to give positive reports on the benefits of psychosocial interventions
for cancer patients, Newell et al. were hesitant to acknowledge most of the reports
as statistically significant, due to serious methodological deficiencies (see
Recommendations for Experimental Design below) in many of the studies
reviewed [8]. Obviously, there is still some debate in the medical world as to the
actual utility of these types of wellness programs [8,9].
The popular press has always been keen to report any news associated
with cancer research, and the use of psychosocial or other nontraditional therapies
is no exception [10,11]. Typically, these reports tend to focus on small numbers
of individuals who have experienced miraculous results, for instance, the longterm remission of cancer thought to be incurable by physicians after the patient
had practiced rigorous meditation. These media reports must be viewed as purely
anecdotal and are no basis for scientific proof that psychological therapies can
“cure” cancer; however, these stories can be encouraging for individuals suffering
the physical and psychological effects of cancer and cancer treatments, and
patients are increasingly willing to enroll in psychosocial self-help programs
[10,11].
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The Hematology and Oncology Specialists Foundation was established in
2001 with the mission to improve the quality of life for the patients being treated
by HOS physicians, and to provide the services for this purpose at no cost to the
patient. Current services include: a mindful meditation group program, a yoga
group program, personal psychological counseling, financial counseling and
assistance, nutritional counseling, lymph edema management, and genetic
counseling. See page A2 for full descriptions of these wellness programs. Since
the inception of the HOS Foundation, 351 cancer patients have participated in one
of the available wellness programs, and each year, the Foundation continues to
increase its budget for these programs The HOS Foundation has found that
patients report considerable improvement in well-being after participating in
every one of the available wellness interventions, and that evidence of
improvement in quality of life can be observed with proper psychometric
instruments. In light of these encouraging signs, the HOS Foundation now seeks
to evaluate the effect of the Foundation’s psychosocial intervention programs on
the quality of life of HOS patients in an objective, scientific manner [12].

Study Objectives
The goal of this pilot study by the HOS Foundation is to collect some
exploratory data from the patients currently participating in the wellness
intervention programs offered by the Foundation; this data will hopefully support
the hypothesis that participation in these programs helps to improve the overall
quality of life experienced by cancer patients. The ultimate goal for the HOS
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Foundation is to publish the results of a large-scale study of the benefits of the
wellness intervention programs in a prestigious oncology journal. The HOS
Foundation will have to seek financial support outside its own resources in order
to fund a large-scale implementation of these wellness programs, to complete a
comprehensive study of the effects of the programs, and to subsequently publish
an article with the results of the study [12]. Pilot data are useful when designing
an experiment because the parameters of the sample, such as mean and standard
deviation, can be used as estimates for the true population parameters. Most
notably, these estimates can be used to determine the ideal sample size for the
full-scale experiment, without having to actually sample a large number of
patients. The results from the exploratory data can then be included in proposals
to obtain the necessary financial assistance.
In the initial study protocols developed by the Foundation for the Yoga,
Meditation, and Counseling Interventions, the primary endpoint is identified as
determining the overall change in quality of life by using the EORTC QLQ-C30.
Some secondary endpoints are to determine the overall change in emotional wellbeing by using the Beck Anxiety Inventory (BAI) and Beck Depression Inventory
(BDI-II) questionnaires, to evaluate the effectiveness of the wellness programs by
using an internally developed patient survey, to identify the primary reasons why
cancer patients seek participation in wellness programs, and to identify the impact
of intervention on medical treatment for cancer, compared to planned treatment
duration. The Foundation is interested in determining the mean percent change in
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quality of life and emotional well-being for the entire patient sample and for the
sample stratified by disease state.

Pilot Data
The data collected in this pilot study are the sole property of the HOS
Foundation and are intended for internal use only. The author’s access to this
data is allowed only in the capacity as a statistical advisor for the HOS
Foundation; therefore, the actual data set cannot be included with this paper.
Relevant descriptive statistics and statistical analyses are summarized below.
Eleven patients completed Beck Stress Related Symptoms (BSRS) surveys
both prior to participation in, and after completion of, an eight-week mindful
meditation program offered by the HOS Foundation. The mean score prior to
participation (BSRS pre-score) was 112.7, with a standard deviation of 43.7. The
mean score after completion of the program (BSRS post-score) was 85.4, with a
standard deviation of 33.5. The variable BSRS change, defined as BSRS prescore minus BSRS post-score, has a mean of 27.4 and a standard deviation of
33.7.
Six patients completed BAI and BDI-II questionnaires both prior to
participation in, and after completing a twelve-week counseling program offered
by the Foundation. The mean BAI pre-score was 25.17, with a standard deviation
of 12.12; the mean BAI post-score was 9.33, with a standard deviation of 6.62.
The variable BAI change, defined as BAI pre-score minus BAI post-score, has a
mean of 15.83 and standard deviation of 7.28. The mean BDI-II pre-score was
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18.67, with a standard deviation of 6.59. The mean BDI-II post-score was 7.67,
with a standard deviation of 6.31, and the variable BDI-II change, defined as BDIII pre-score minus BDI-II post-score, has a mean of 11.0 and a standard deviation
of 3.1. See page B1 for summary charts of descriptive statistics.

Analysis
All statistical analyses for this study were conducted with Minitab®
Release 14 Statistical Software for Windows. The significance level (α) used
throughout this paper is α = 0.05.

Results
To test whether or not participation in the meditation program had an
effect on BSRS scores, a one-sample t-test was used to test if the BSRS change
variable is significantly different from zero. The researchers are interested in
showing whether participation in these wellness program provides a benefit to
patients, so in this case, it is logical to conduct a one-tailed t-test to test the
alternate hypothesis that the mean of the BSRS change score is greater than zero.
The t-score for this test is t = 2.70 (p = 0.011). Thus, the null hypothesis that the
mean BSRS change is equal to or less than zero can be rejected, and it can be
concluded that the true BSRS change mean is significantly greater than zero. A
post hoc power analysis revealed that this one-tailed test has a power of 0.806 to
detect a difference of 27.4, assuming a standard deviation of 33.7 and using a
sample size of 11. This is a surprisingly high power for a small sample size.
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Therefore, it is reasonable to conclude that participation in the meditation
intervention decreased the patients’ scores on the BSRS survey.
The same procedure can be used to test if the BAI change and BDI-II
change scores are significantly greater than zero for the counseling intervention
program; again, a one-tailed test was used in each instance. The t-score to test
whether BAI change is greater than zero is t = 5.33 (p = 0.002); therefore, the null
hypothesis that BAI change is equal to or less than zero can be rejected. A post
hoc power analysis revealed a power of 0.997, which of course is very high. The
t-score to test if BDI-II change is greater than zero is t = 8.70 (p < 0.001), so
again, the null hypothesis that BDI-II change is equal to or less than zero can be
safely rejected. A power analysis revealed an extremely high power > 0.999.
Thus, it is quite reasonable to conclude that participation in the counseling
program reduced patients’ scores on the BAI and BDI-II questionnaires. See page
B1 for a summary of hypotheses tests.
The researchers should also be interested to see if the pilot data show any
differences between effectiveness of the wellness interventions, as this is one of
the questions they want to explore in the full-scale study. Unfortunately, for this
pilot study, the two groups of patients completed different psychometric surveys,
thus making it difficult to make any comparisons. Notice that patients enrolled in
the meditation program improved their BSRS scores by an average of 24.3%, and
that patients enrolled in the counseling program improved their BAI scored by an
average of 62.8% and BDI-II scores by an average of 58.9%. However,
comparing the mean percent changes in psychometric survey scores between
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groups would not be very meaningful, as one survey measured stress levels, one
measured anxiety levels, and the other measured depression levels.

Recommendations for Experimental Design
There are several methodological deficiencies evident regarding the
original study schemas and the collection of the pilot data. The most glaring fault
is the small size of the samples; the researchers were very fortunate to have
obtained any significant results from such a small sample. In order to assure that
a large-scale study will also yield significant results, if in fact the results truly
should be significant, the sample size needs to be considered carefully.
Determining the appropriate sample size for a one-sample t-test is fairly
straightforward; all the researchers need to do is decide how much of a decrease
in stress or anxiety or depression scores is medically significant, and, given an
estimate of variability within the population, a power analysis will give the
sample size necessary for the same decrease to be statistically significant as well.
However, when trying to determine the appropriate sample sizes for more
complicated statistical procedures such as ANOVA, several other serious
methodological problems become evident. See page B2 for tables of powers and
sample sizes for one-tailed one-sample t-tests. See pages B3-B4 for a discussion
on interpreting the meaning of power.
There was unnecessary and counterproductive variation regarding the
administration of the different treatments and psychometric tools used in the pilot
study. The patients in the meditation group and the patients in the counseling
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group completed different sets of psychometric questionnaires; therefore, it was
impossible to compare the change in quality of life between the two groups. The
researchers are interested in whether meditation, yoga, or some other type of
nontraditional therapy improves the quality of life for cancer patients to a
different degree than a traditional psychological counseling program. In order to
do this, the same measurement tool must be used for all treatment groups. If
participation in these wellness programs really does have an effect on quality of
life, then the data will show this, no matter which set of psychometric surveys is
employed, for each of these surveys is widely accepted in psychological and
medical research to be a credible and accurate indicator of psychological states.
Also, the pilot schema called for a 12-week program that met once a week
for counseling and yoga, while the meditation program met twice a week for 8
weeks. In order to compare the effects of one program with the effects of another,
it is important for the administration of treatments to be as homogenous as
possible. For example, if participation in the meditation group results in a greater
reduction in stress, it is possible that the full effect is not a result of the meditation
itself, but that any intervention program that met twice a week versus once a week
would have an effect similar to the meditation program. When setting up a
scientific experiment that is intended to show the effect of one variable on
another, it is very important to control and standardize all the other factors that
may also have an effect on the response variable. Factors that cannot be
completely controlled must either be completely randomized, or measured and
tested for any effects on the response variable, as in the instance of covariates.
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Finally, Newell et al.(2002) noted that a very important consideration
absent from many studies of this nature is the inclusion of a control group [8]. It
is important to have a control group to account for any natural time trends, for it is
reasonable to expect that patients not participating in any intervention programs
may experience some change in their mood or stress levels over a period of time.
Comparing a measure such as the mean BAI change over a period of time for an
intervention group to the mean BAI change for a control group will indicate
whether participation in an intervention has a different effect on quality of life
than non-participation over the same time period.
The easiest way to implement a control group for this type of study, where
the patients constitute a convenience sample, is to create a randomized wait-list
control group. In this instance, because there were three different planned
treatments, the control group could be created in the following manner: take the
group of patients who want to enroll in meditation practice and randomly assign
3/4 to the meditation group and 1/4 to the wait-list group; take the group of
patients who want to enroll in yoga practice and randomly assign 3/4 to the yoga
group and 1/4 to the wait-list group; similarly, take the patients who want to
enroll in counseling and randomly assign 3/4 to the counseling group and 1/4 to
the wait-list group. Thus, there will be a total of 4 groups: 3 treatment groups and
1 control group. Patients should be randomly distributed in terms of demographic
variables such as age or type of cancer. See page A3 for a copy of the memo sent
to the researchers at the HOS Foundation by the author, concerning these
recommendations.
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Revised Experimental Design
Based on the considerations presented above, the HOS Foundation has
developed a revised study protocol. The relevant details of the new protocol are
summarized below, along with additional discussion of the revised protocol.
The primary goal of the revised study will be to determine the
effectiveness of each of the intervention programs in improving the patients’
quality of life. Secondary objectives will be to determine the effectiveness of
each intervention program versus the others, to determine whether the
effectiveness of intervention programs differs for patients receiving adjuvant or
non-adjuvant chemotherapy (patients with early stage cancer or late-stage cancer),
and to determine if any other correlations exist between demographic or clinical
parameters and the effect of participation in intervention programs on patients’
quality of life.
The patient population consists of consecutive patients due to begin their
prescribed chemotherapy and/or radiation therapy regimen after a diagnosis of
cancer. Prior to beginning therapy, patients will be given an information packet
describing the wellness intervention programs available from the HOS
Foundation and the plans to evaluate these programs in a scientific study. All
patients will have the option to participate in either the meditation group program
or the yoga group program. Certain patients may be referred for psychological
counseling by their physician, oncology nurse, or social worker, or self-referred
for symptoms of psychological distress. Patients suffering from clinically evident
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lymph edema may be referred for lymph edema therapy by their physician or
oncology nurse. Patients may choose not to participate in any intervention if that
is their wish. All patients, including those who do not wish to participate in an
intervention program, will be asked to consent to participating in this study. It is
the patient’s right to refuse participation in the study without compromising the
quality of treatments they will receive from the HOS Foundation or HOS
physicians.
The HOS Foundation originally wanted to include financial counseling as
a group in this study; however, the author will advise against this. Patients
typically meet with a financial counselor for only one or a few sessions, not for
six or 12 weeks, as the yoga, meditation, and personal counseling programs do.
Also, the number of patients enrolled in the financial counseling program is much
smaller than the number of patients participating in the yoga, meditation and
personal counseling groups. These were two reasons why the HOS Foundation
had previously decided to exclude nutritional counseling and genetic counseling
from the study. Lymph edema management can be reasonably included in this
study because lymph edema treatments, although based on individual patient
need, are likely to last for at least six weeks, and probably for a long as the full
12-week length of the study. In addition to recruiting patients for the study who
do not wish to participate in an intervention, the researchers will take the author’s
advise and create a wait-list control group consisting of patients who are
interested in participating in either the meditation or yoga programs.
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Thus, patients who consent to the study will be divided into the following
treatment groups: (1) non-participation group: patients who do not want to
participate in a wellness program; (2) wait-list group: patients who want to
participate in either the meditation or yoga programs, who have been randomly
assigned to the wait-list control group; (3) meditation group: patients who want to
participate in the meditation program and have been randomly assigned to begin
the program immediately; (4) yoga group: patients who want to participate in the
yoga program and have been randomly assigned to begin the program
immediately; (5) personal counseling group: patients who have been referred for
psychological counseling; (6) lymph edema group: patients who have been
referred for lymph edema treatment.
All patients participating in the study will be asked to complete the QLQC30 psychometric survey at three time points: just prior to beginning an
intervention, six weeks after beginning the wellness intervention, and 12 weeks
after beginning the wellness intervention. One exception is that the wait-list
group will complete the surveys at time 1, then begin the wellness program of
their choice at time 2 (six weeks later), and then continue to complete the
psychometric surveys at the regular time intervals, as it is felt that 12 weeks
would be too long for patients to wait to begin an intervention. In addition, the
personal counseling group will complete BAI and BDI-II questionnaires at each
time point, in order for therapists to monitor the anxiety and depression levels of
their patients more closely. Patients referred for lymph edema management will
be continuously monitored by circumferential limb measurements, as is standard
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for this type of therapy. At any time, patients assigned to the non-participation or
wait-list groups may immediately begin the appropriate intervention program if,
in the opinion of the HOS staff, they would be harmed by undue delay. These
patients should continue to complete the psychological questionnaires at the
regular intervals, and, if possible, these data can be incorporated into the study.
Clinical and demographic data will be obtained for each patient, according to
HIPPA guidelines, and with patient consent.
The EORTC QLQ-C30 was chosen as the main psychometric instrument
for this study because it is widely accepted in oncology literature to be the “gold
standard” of quality of life measurements for cancer patients [7,12,13]. The
QLQ-C30 was developed by the European Organization for Research and
Treatment of Cancer in order to specifically measure the global health status and
overall quality of life (QoL), as well as several “functional scales” (e.g. social
functioning, physical functioning), and several common symptoms of cancer and
cancer therapies (e.g. fatigue, nausea); several supplementary modules are also
available to measure symptoms associated with specific types of cancer (e.g.
breast cancer, lung cancer). The QLQ-C30 questionnaire is a popular choice for
chemotherapy studies because of its efficiency; the questionnaire is only 30
questions long, and yet it provides several different measurements of quality of
life for cancer patients. The QLQ-C30 has undergone extensive evaluation for
internal validity reliability and is now in its 3rd version [5]. A higher number for
global QoL and functional scales indicates a higher(better) level of QoL or
functioning, while a higher number for symptoms scales represents a
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higher(worse) level of symptoms. See pages A5-A8 for a specimen of the QLQC30 questionnaire and scoring instructions.

Recommendations for Statistical Analysis
Unfortunately, the small amount of pilot data collected for this study did
not allow for a very sophisticated statistical analysis. In a study such as this,
where there are several levels of treatments being tested simultaneously on a
population defined by many characteristics, there are many types of statistical
tools available to researchers. If the researchers can properly collect the data from
the full-scale study, the statistical analysis should be quite interesting. Consider
the data set on page B7; this is a completely fictitious data set which will merely
serve as an example to illustrate the kinds of data and statistical procedures that
may be appropriate to analyze when the study is complete. See page B6 for the
definitions of the variables used in the data set. The following guideline for the
statistical analysis for this study will focus on comparing the effectiveness of the
different treatment groups by comparing the patients’ scores on the EORTC
QLQ-C30. Evaluation of the BAI and BDI-II scores collected from the
counseling group and the limb measurements from the lymph edema therapy
group would be analogous to the analysis done for the pilot data (one-sample,
one-tailed t-tests).
The first step in any statistical analysis is always straightforward: describe
the characteristics of the samples by calculating several univariate descriptive
statistics, such as mean, median, variance, range etc. In this case, the researchers
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will want to describe the demographic and clinical parameters of the patient
samples, both overall, for each treatment group, and for each type of
chemotherapy. The researchers will also want to summarize the scores from the
QLQ-C30 at each time point, both overall, for each treatment group, and for each
type of chemotherapy. The final part of this descriptive analysis should be to
define “percent change” variables, for example, %∆QoL(2-1) = (QoL2 –
QoL1)/QoL1 is the percent change in quality of life from week 0 to week 6, and
%∆SF(3-1) = (SF3 – SF1)/SF1 is the percent change in social functioning from
week 0 to week 12. Reporting the patients’ changes in quality of life in terms of
percent change, rather than absolute change, will show the patients’ improvement
relative to their initial QoL score before beginning an intervention. This will be a
more appropriate measure of improvement because patients will begin the study
with widely varied QoL scores. The researchers may decide to analyze all subscores from the QLQ-C30 (see page A8), or choose specific items to evaluate, for
example, testing improvement in functional scales, but not for physical
symptoms. Either way, the procedure for analyzing each sub-score will be
exactly the same.
The next step should be to analyze the data to test the researchers’
hypothesis that participation in a wellness intervention programs improves the
quality of life for cancer patients. Usually, in medical or psychological studies,
statistical results are reported in terms of t-tests, regression equations, or ANOVA
tables. A one-sample t-test will show whether a sample’s mean is significantly
different from zero, a two-sample t-test will show whether the means of two
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different groups are significantly different from each other, and an ANOVA table
will show whether the means of several groups are significantly different.
Regression analysis can give a formula for predicting the value of one variable
based on the value of other variables.
These statistical tests are easy to evaluate and report; if the p-value
associated with the test statistic (either t or F) is less than the α-level, then the null
hypothesis, that the means are all equal or equal to zero, can be rejected.
However, to actually compute all these tests individually is inefficient. The
ANOVA table is not difficult to compute, and a significant F statistic indicates
that various two sample t-tests may further illuminate exactly which of the means
of the treatment groups are actually different from each other. However, selecting
the parings for the tests and partitioning the data into the appropriate groups for
each test is extremely tedious. Regression analysis can also be laborious at times.
For example, the QoL scores can be regressed against variables such as age, sex,
race, cancer, chemo, etc. if the categorical variables are first modified by a
process known as coding dummy variables. A dummy variable takes the value
one if the experimental unit exhibits that property, it takes the value zero
otherwise. For instance, the variable “sex” can be renamed “female”, and instead
of a column of Fs and Ms, the column will contain 1s and 0s. A much more
efficient and elegant method for computing the exact same regression
coefficients, F statistics, and t statistics as these separate procedures above is to
evaluate a general linear statistical model (GLM).
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The researchers are interested in the effects of each wellness program on
the quality of life for the patients, but they are also interested to see if patients
receiving adjuvant or non-adjuvant chemotherapy differ in their response to the
wellness interventions. There are six different types of interventions (four
wellness programs and two “control” groups), and there are two levels of
chemotherapy; thus, the experimental design for this study is a 6×2 factorial
design. However, there are also several variables which may also influence the
patients’ quality of life measurements; the demographic and clinical variables to
be recorded for each patient are: sex (male or female), age (≤ 50 years old or > 50
years old), race (Asian, Black, Hispanic, White etc.) and type of cancer (breast,
colon, leukemia, lung, ovarian, prostate etc.). These variables should be included
in the linear model as covariates. Thus the GLM is:
yijk = µ + β1(sexk) + β2(agek) + β3(racek) +β4(cancerk) + trtmnti + chemoj
+ (trtmnt*chemo)ij + eijk; i = 1 to 6; j = 1 to 2; k = 1 to nk.
Where yijk is the psychometric survey score (QoL, PF, EF etc.) for the kth patient
in the ith treatment group with the jth type of chemotherapy; µ is the grand mean
of survey scores for the entire patient sample; β1 is the coefficient of linear
regression of y on the variable sex; β2 is the regression coefficient of y on age; β3
is the regression coefficient of y on race; β4 is the regression coefficient of y on
cancer; trtmnti is the fixed effect of treatment i; chemoj is the fixed effect of
chemotherapy type j; (trtmnt*chemo)ij is the interaction effect between treatment i
and chemotherapy type j; and eijk is the experimental error.
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In a model such as this, where the covariates are categorical variables, it
may be helpful to think of them as different blocks and the effects that they
produce on y as blocking effects; however, keep in mind that determining the
regression coefficients will still be an important part of the analysis. The
researchers should pre-determine the linear contrasts, such as ‘non-participation
vs. others’ or ‘non-traditional therapies vs. psychological counseling’, they wish
to estimate and test. An ANCOVA (Analysis of Covariance) of this model with
the planned linear contrasts and solutions will automatically calculate all the F
statistics, t statistics, and regression coefficients of interest. The F statistic for
each βr will show whether there is any significant correlation between survey
scores and the demographic and clinical variables. A two-way ANOVA of the
response variable by the two factors of treatment and chemotherapy type is
automatically imbedded in the ANCOVA. The F-scores from the ANOVA will
show whether there are any significant effects from the different treatments, from
the two types of chemotherapy, or from any interaction between treatment and
chemotherapy type. The tests of linear contrasts calculate the t-scores for the
differences between the various groupings of patients as decided by the
researchers. This ANCOVA procedure will give the same results as computing
separate ANOVA tables, t-tests, and regression analysis, but it is much more
efficient, especially with one of the many powerful statistical computing packages
available.
The same model can be applied with the response variable defined as one
of the “change” variables; in general terms, yijk = (qijk(b) – qijk(a))/qijk(a). The
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ANCOVA for this model will show whether there are any significant regression
coefficients. The automatic ANOVA will show whether there are significant
differences in the percent change in quality of life experienced by the cancer
patients in the different treatment and chemotherapy groups. Finally, the linear
contrasts will show whether there is any difference in the percent change in
quality of life between specific groups of patients.
Finally, the researchers should use an a priori power analysis to estimate
the number of patients to recruit for this study. Recall the discussion of power
from above (see page B3 for a further discussion). The researchers need to decide
how much of an improvement in quality of life scores represents a significant
medical or psychological improvement: 10%, 20%, etc. Then, using an estimate
of the population variance, they can determine an estimate for the ideal sample
size for each treatment group and overall. Unfortunately, at the time this paper
was written, the author did not have such an estimate of variation in order to
conduct the a priori power analysis because the researchers did not use the
EORTC QLQ-C30 to collect any of the pilot data.
The researchers have two options: either collect more pilot data using the
same psychometric instrument that they intend to use for the full-scale study, or
search the relevant literature for a study that used the QLQ-C30 questionnaire on
a similar population of patients and use the sample standard deviation reported in
another study as an estimate of the population standard deviation. There are
advantages and disadvantages for each option. Reviewing the literature would be
less time consuming, but there is no guarantee that a suitable estimate of
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population variance can be found. Collecting more pilot data would be more
costly, but the researchers could be more confident that the estimate of the
variance calculated would be more accurate for the present patient population.
The researchers should also be aware that some patients who begin the
study may drop out before the study is complete. Patients may be lost to followup due to becoming too ill to participate in the programs or death. Patients may
also simply drop out of the program for personal reasons, such as moving out of
the area or are not enjoying the programs offered. In order to have a large enough
sample for a powerful statistical analysis, the researchers should take these factors
into consideration and overestimate the initial patient sample size to ensure that
enough patients will complete the study.

Conclusion
The HOS Foundation strives to provide the best possible services for HOS
patients, and an integral part of these services are several psychosocial
interventions, or “wellness programs,” aimed at helping cancer patients to cope
with the physical and psychological stresses of their disease. Non-traditional
cancer therapies are becoming increasingly popular among patients, and research
on the effects of these therapies features prominently in oncology literature. The
HOS Foundation plans to evaluate the effectiveness of their wellness programs in
a scientific study and later publish an article with the results of this study.
HOS Foundation first conducted a pilot study to collect some exploratory
data. The pilot data showed that participation in a meditation program
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significantly reduced the symptoms of stress experienced by the patients (t = 2.70,
p = 0.011), and that participation in psychological counseling significantly
reduced the anxiety and depression levels of the patients (t = 5.33, p = 0.002; t =
8.70, p < 0.001, respectively). Based on the results of the pilot data, assessment
of the original study protocol, and a review of the relevant psycho-oncology
literature, the author has developed an extensive guideline for the experimental
design and statistical analysis for the full-scale study.
The HOS researchers are interested in determining the effects of six
different treatment groups: non-participation, wait-list, yoga, meditation,
psychological counseling, and lymph edema therapy, and two different types of
chemotherapy: adjuvant and non-adjuvant, on the quality of life experienced by
the HOS patients. Thus, the design for this experiment is a 6×2 factorial design,
with several possible covariates: age, cancer diagnosis, race, and sex.
Researchers should use an ANCOVA and ANOVA with planned linear contrasts
to test the general hypothesis that participation in an intervention increases the
quality of life experienced by the patients. Evaluation of a GLM will yield the
same test statistics (F-scores, t-scores, and regression coefficients) as are
commonly reported in medical and psychological journals; however, this
procedure is much more efficient than performing many separate calculations.
This study will be an important contribution to the body of oncology
literature. Many studies have reported on the benefits of various non-traditional
cancer therapies; however, no study has yet to compare the effects of these types
of wellness interventions to those of traditional psychological counseling.
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